IBM’s $12.5 Billion AI Backlog and a 100-Billion-Transistor Chip: Why the Market Still Shrugs
26.06.2026 - 16:17:32 | boerse-global.de
For all the noise around IBM’s research labs and its cybersecurity partnerships, investors are keeping their wallets firmly shut. The stock has shed about 8% year-to-date, hovering near €227.55, despite a cascade of announcements that would normally lift a legacy tech giant. Two very different initiatives – a sub?nanometre chip breakthrough and a multi?billion?dollar cyber defence alliance – are being greeted with a collective yawn on Wall Street.
The more eye?catching development comes from IBM’s semiconductor unit. The company has unveiled the first chip built with a process below one nanometre, using a novel 3D architecture it calls NanoStack. By stacking transistors vertically, IBM crams roughly 100 billion transistors onto the area of a fingernail – double the density of current standards. The payoff: either 50% more performance or a 70% cut in energy consumption. That kind of efficiency could slash the training time for large language models to just two weeks, a leap that industry insiders believe extends the life of Moore’s Law by another decade.
Yet the commercial payoff is distant. IBM will not manufacture these chips itself; it intends to license the technology to partners such as Samsung and Rapidus, with volume production not expected until the early 2030s. For a market that measures success in quarterly increments, five years of waiting is an eternity. The stock briefly touched €226.00 in recent sessions, a roughly 9% decline from the start of the year, and remains stubbornly below its 200?day moving average of just under €236.
Should investors sell immediately? Or is it worth buying IBM?
While the chip news grabs headlines, the company’s nearer?term strategy relies on shoring up its software and services business against fast?moving cyber threats. IBM has joined forces with Palo Alto Networks and its own Red Hat subsidiary to create a “shield?and?fix” workflow under Project Lightwell, a multibillion?dollar open?source security initiative. Palo Alto’s virtual patch technology blocks attacks at the network layer, buying time for IBM and Red Hat to repair the underlying software. The urgency is driven by artificial intelligence: as Palo Alto CEO Nikesh Arora notes, AI has compressed the window between vulnerability discovery and exploitation from weeks to minutes. The alliance will target weaknesses in commercial applications, healthcare systems, and connected devices.
To finance these offensive and defensive moves, IBM has extended two revolving credit lines by one year each, keeping a total of $10 billion in capacity available well into the next decade. The cushion comes as the generative?AI pipeline swells: the backlog in that area reached $12.5 billion, boosted by new partnerships including one with OpenAI.
The market’s next chance to reassess the story comes on 22 July, when IBM reports second?quarter results. Analysts expect earnings of $3.00 per share on revenue of $17.85 billion. The consensus price target sits at roughly €259, implying a 15% upside from current levels – but that hope hinges on the company proving that its research leadership can translate into growth in the here?and?now software business. Until then, the technological brilliance remains a long?term promise that investors are content to ignore.
Ad
IBM Stock: New Analysis - 26 June
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
